Logo

American Heart Association

  16
  0


Final ID: MP2800

Exome Wide Rare Variant Analysis Identifies Novel Genes Associated with Coronary Artery Disease

Abstract Body (Do not enter title and authors here): Background: Cardiovascular disease is a leading cause of morbidity and mortality worldwide, and coronary artery disease is its most common subtype. While common variants have been extensively studied, much of the genetic architecture of coronary artery disease remains unexplained. Rare coding variants offer an opportunity to discover novel disease-associated genes with direct biological relevance.
Research question: Can we identify genes carrying rare loss of function variants associated with coronary artery disease, and what are their broader cardiometabolic effects?
Methods: We analyzed sequencing data from three large biobanks including UK Biobank with 59,236 cases and 422,329 controls, All of Us with 48,395 cases and 267,650 controls, and Mass General Brigham Biobank with 10,400 cases and 39,888 controls, totaling over 847,000 individuals. We performed gene-based burden testing aggregating rare loss of function variants to identify genes associated with coronary artery disease. Our mixed effects models were adjusted for age, sex, population structure, and relatedness. Genes reaching statistical significance (P<3.20x10-6) were further evaluated using phenome-wide association of 1587 PheCodes and 7 cardiometabolic traits.
Results: Six genes were significantly associated with coronary artery disease: LDLR (OR 4.74 P=1.06 ×10-19), TTN (OR 1.49, P=8.59x10-22), PKD1 (OR 1.67, P=1.25×10-6), ADGRL1 (OR 4.2, P=7.24x10-7), RMC1 (OR 2.84, P=1.58×10-6), and RBM12 (OR 3.46, P=2.63×10-6). ADGRL1, RMC1, and RBM12 showed significant associations despite no prior implication in coronary or cardiometabolic traits, in contrast to LDLR, TTN and PKD1, which have established roles. Phenome wide analysis revealed links between the novel genes and conditions such as hypertension, obesity, diabetes, and arrhythmias. Risk factor analyses showed that ADGRL1 and RMC1 were associated with higher body mass index and triglycerides and lower high density lipoprotein cholesterol. RBM12 was additionally associated with elevated low density lipoprotein cholesterol.
Conclusions and Relevance: We identified five novel genes associated with coronary artery disease through exome wide rare variant analysis. Follow up phenome wide and risk factor analyses suggest functional relevance, particularly for ADGRL1, RMC1, and RBM12, offering new biological insights into coronary artery disease.
  • Choi, Seung Hoan  ( Boston University School of Public , Boston , Massachusetts , United States )
  • Koyama, Satoshi  ( The Broad Institute , Cambridge , Massachusetts , United States )
  • Nakao, Tetsushi  ( The Broad Institute , Cambridge , Massachusetts , United States )
  • Hornsby, Whitney  ( The Broad Institute , Cambridge , Massachusetts , United States )
  • Jurgens, Sean  ( Broad Institute and Amsterdam UMC , Amsterdam , Netherlands )
  • Ellinor, Patrick  ( The Broad Institute , Cambridge , Massachusetts , United States )
  • Natarajan, Pradeep  ( Massachusetts General Hospital , Brookline , Massachusetts , United States )
  • Peloso, Gina  ( Boston University School of Public , Boston , Massachusetts , United States )
  • Author Disclosures:
    Seung Hoan Choi: DO NOT have relevant financial relationships | Satoshi Koyama: No Answer | Tetsushi Nakao: DO have relevant financial relationships ; Speaker:Kowa Co., Ltd.:Past (completed) | Whitney Hornsby: No Answer | Sean Jurgens: DO NOT have relevant financial relationships | Patrick Ellinor: No Answer | Pradeep Natarajan: DO have relevant financial relationships ; Researcher:Amgen, Genentech / Roche:Active (exists now) ; Other (please indicate in the box next to the company name):Vertex Pharmaceuticals (spousal employment):Active (exists now) ; Ownership Interest:Bolt, Candela, Mercury, MyOme, Parameter Health, Preciseli, TenSixteen Bio:Active (exists now) ; Consultant:Allelica, CRISPR Therapeutics, Genentech/Roche, HeartFlow, Magnet Biomedicine:Past (completed) ; Consultant:AstraZeneca, Blackstone Life Sciences, Bristol Myers Squibb, Eli Lilly & Co, Esperion Therapeutics, Foresite Capital, Foresite Labs, GV, Merck, Novartis, Novo Nordisk, TenSixteen Bio, Tourmaline Bio:Active (exists now) ; Researcher:Allelica, Novartis:Past (completed) | Gina Peloso: DO have relevant financial relationships ; Speaker:Novartis:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Multi-Omic Insights into Coronary Artery Disease 2

Monday, 11/10/2025 , 01:45PM - 02:45PM

Moderated Digital Poster Session

More abstracts on this topic:
More abstracts from these authors:
Integrative Metabolomic Analysis of Triglyceride-Independent Lipoprotein Lipase Pathway Mechanisms for Coronary Artery Disease

Dron Jacqueline, Xue Liying, Koyama Satoshi, Schuermans Art, Lee Jiwoo, Honigberg Michael, Hornsby Whitney, Peloso Gina, Natarajan Pradeep

Identification of functional proteins in peripheral artery disease using proteogenomic analysis of European and African populations

Flores Alyssa Monica, Schuermans Art, Tian Haodong, Nakao Tetsushi, Koyama Satoshi, Urbut Sarah, Yu Zhi, Natarajan Pradeep

You have to be authorized to contact abstract author. Please, Login
Not Available